APR 14, 2015 10:22 AM PDT

New Cancer Drug Could Result from 6 Molecules That Block HuR

WRITTEN BY: Will Hector
Scientists have found six molecules that block HuR, an "oncoprotein" linked to cancer that was thought to be "undruggable."

The findings could lead to a new class of cancer drugs, researchers say.

HuR has been detected at high levels in almost every type of cancer tested, including cancers of the colon, prostate, breast, brain, ovaries, pancreas, and lung.

"HuR inhibitors may be useful for many types of cancer," says Liang Xu, associate professor of molecular biosciences at the University of Kansas. "Since HuR is involved in many stem cell pathways, we expect HuR inhibitors will be active in inhibiting ‘cancer stem cells,' or the seeds of cancer, which have been a current focus in the cancer drug discovery field."

HuR has been studied for many years, but until now no direct HuR inhibitors have been discovered.

"The initial compounds reported in this paper can be further optimized and developed as a whole new class of cancer therapy, especially for cancer stem cells," Xu says.

PRECISION MEDICINE
"The success of our study provides a first proof-of-principle that HuR is druggable, which opens a new door for cancer drug discovery. Many other RNA-binding proteins like HuR, which are so far undruggable, can also be tested for drug discovery using our strategy."

For the study, published in ACS Chemical Biology, researchers evaluated about 6,000 compounds from both the KU Chemical Methodologies and Library Development Center and the Food and Drug Administration in a process known as "high throughput screening," hunting for compounds that obstruct HuR's interface with healthy human RNA.

"A cancer-causing gene, or oncogene, makes RNA, which then makes an oncoprotein that causes cancer or makes cancer cells hard to kill, or both," Xu says. "This is the problem we're trying to overcome with precision medicine."

The HuR-RNA binding site is like a long, narrow groove, not a well-defined pocket seen in other druggable proteins targeted by many current cancer therapies.

"HuR tightly binds to RNA like a hand," Xu says. "The HuR protein grabs the ‘rope'-or the RNA-at a site called ‘ARE' on the rope. We aimed to find a small-molecule compound that makes the hand release the rope by competing with ARE of the RNA."

(Sources: University of Kansas; Futurity.org)
About the Author
  • Will Hector practices psychotherapy at Heart in Balance Counseling Center in Oakland, California. He has substantial training in Attachment Theory, Hakomi Body-Centered Psychotherapy, Psycho-Physical Therapy, and Formative Psychology. To learn more about his practice, click here: http://www.heartinbalancetherapy.com/will-hector.html
You May Also Like
JUL 16, 2021
Drug Discovery & Development
Machine Learning Ranks Cancer Drugs by Efficacy
JUL 16, 2021
Machine Learning Ranks Cancer Drugs by Efficacy
A machine learning algorithm developed by researchers at the Queen Mary University of London in the UK can rank cancer d ...
AUG 24, 2021
Technology
CRISPR Helps Identify New Therapeutic Target for Leukemia
AUG 24, 2021
CRISPR Helps Identify New Therapeutic Target for Leukemia
Researchers may have found a new druggable target in patients with acute myeloid leukemia (AML), thanks to a CRISPR scre ...
SEP 20, 2021
Cancer
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
SEP 20, 2021
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
For the past several decades, cancer antigen 125 (CA 125), a protein located on the surface of ovarian cancer cells, has ...
OCT 25, 2021
Cancer
Could Pomegranates Play a Role in Cancer Prevention or Treatment?
OCT 25, 2021
Could Pomegranates Play a Role in Cancer Prevention or Treatment?
Pomegranate (Punica granatum L) is an ancient fruit grown primarily in western Asia and Mediterranean regions.  ...
NOV 05, 2021
Cancer
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
NOV 05, 2021
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
Every year, Labroots hosts an exciting series of Virtual Events that focus on various scientific topics. These virtual m ...
NOV 18, 2021
Immunology
Ultrasound Helps Shuttle Cancer-Killing Antibodies to the Brain
NOV 18, 2021
Ultrasound Helps Shuttle Cancer-Killing Antibodies to the Brain
Antibody therapies harness the immune system's power to fight a broad spectrum of diseases, from cancer to infectiou ...
Loading Comments...